Physician

Ronald P Kubica, MD

According to 2025 Medicare claims, Ronald Kubica, MD (NPI: 1275532970) practices hematology/oncology in the Albuquerque, NM market, with the plurality of this provider's patient population coming from Bernalillo, NM. This provider's primary affiliated billing organization is NEW MEXICO ONCOLOGY HEMATOLOGY CONSULTANTS, LTD. (NPI: 1164475232; TIN: 850367056) and primary practice location at 87109-4495. Kubica is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Kubica's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 921 traditional Medicare patients, billed 141,429 HCPCS/CPT codes, and received $2,657,168 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,379 prescription claims across 235 beneficiaries totaling $4,160,695 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 129 claims. Open Payments data shows 15 records totaling $4,452. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $91,916 to $2,657,168. Similarly, Part D prescription costs have moved sharply higher in recent years, from $601,522 to $4,160,695. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $6,024 to $1,585.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	394	1,233	$91,916
2016	352	1,230	$91,929
2017	353	1,309	$97,767
2018	332	6,784	$155,641
2019	708	87,940	$1,713,919
2020	719	114,382	$2,153,122
2021	784	122,684	$2,426,639
2022	945	144,678	$2,811,251
2023	806	129,692	$2,256,022
2024	921	141,429	$2,657,168

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	158	717	$601,522
2016	148	719	$779,135
2017	148	738	$754,949
2018	136	591	$675,249
2019	208	991	$1,667,448
2020	196	1,116	$1,882,096
2021	215	1,052	$1,728,984
2022	241	1,247	$3,022,006
2023	226	1,314	$3,674,961
2024	235	1,379	$4,160,695

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	67	$5,771
2016	N/R	85	$5,010
2017	N/R	42	$14,737
2018	N/R	44	$6,431
2019	N/R	24	$577
2020	N/R	35	$1,763
2021	N/R	11	$818
2022	N/R	58	$1,856
2023	N/R	73	$4,156
2024	N/R	129	$5,070

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	222	636	$129
96413	Administration of chemotherapy into vein, 1 hour or less	102	321	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	314	440	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	181	223	$55
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	515	849	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	72	2,152	$977,540
Xtandi	Enzalutamide	41	1,230	$554,893
Pomalyst	Pomalidomide	14	392	$304,045
Jakafi	Ruxolitinib Phosphate	18	540	$303,216
Lenalidomide	Lenalidomide	22	583	$218,358

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4409	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	13	$996
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$983
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	13	$788
A4432	Ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), each	N	N/R	13	$498
J8521	Capecitabine, oral, 500 mg	N	N/R	12	$465

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$302	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$4,150	Gilead Sciences, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ronald P. Kubica, MD?

Tedicare shows public-source Medicare data for Ronald P. Kubica, MD (NPI 1275532970), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ronald P. Kubica, MD have ACO affiliation data?

Ronald P. Kubica, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Ronald P. Kubica, MD?

Ronald P. Kubica, MD is linked to NEW MEXICO ONCOLOGY HEMATOLOGY CONSULTANTS, LTD. (billing NPI 1164475232) in the available physician profile data.

Does Ronald P. Kubica, MD have Open Payments data?

Ronald P. Kubica, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.